Ralf Westenfeld

Ralf Westenfeld

Chief, Division of Cardiology, Pulmonology and Vascular Diseases

University Hospital Düsseldorf, Germany

  • LinkedIn
  • Radcliffe

Media

ESC 2018: Why use percutaneous ventricular assist devices?

Nicolas M Van Mieghem, Ralf Westenfeld, Jacob E Møller, et al

Watch time: 6m 34s

Articles by Ralf Westenfeld, Chief, Division of Cardiology, Pulmonology and Vascular Diseases

PROTECT-Kidney Randomised Controlled Trial: MRI Pilot Study

Ralf Westenfeld,

Published:

Citation: Interventional Cardiology 2024;19(Suppl 1):15–6.

DOI:

https://doi.org/10.15420/icr.2024.19.S1
A35 - High Serum Phosphate Concentrations after ROSC in OHCA patients with MCS Indicates Favourable Outcome

Fabian Voss, Ralf Erkens, Laura Heyng, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A35.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
A15 - Impella Mechanical Circulatory Support for Takotsubo Syndrome with Shock

L Christian Napp, Jacob E Møller, Federico Pappalardo, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A15.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
A9 - High-resolution Respirometry Reveals Enhanced Myocardial Mitochondrial Ketone Oxidation after Ventricular Unloading

Elric Zweck, V Burkart, C Wessel, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A9.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
Impella Support Improves Pulmonary Congestion in Cardiogenic Shock

Ralf Westenfeld,

Published:

Citation: Interventional Cardiology Review 2017;12(2 Suppl 2):18-19.

DOI:

https://doi.org/10.15420/icr.2017.12.2.S2